MSS31 Medicines for Parkinson’s Disease
MSS31 Medicines for Parkinson's Disease document to support safe prescribing and administration of these time-critical medicines.
We know that some of our PDF documents may not be accessible to everyone but we’re working on it. As documents come up for renewal we aim to make them more accessible. In the meantime, if you need any of our policies in a different format please email [email protected]
Showing 29 Publications filtered by Medication Safety Series
-
-
Serotonin Syndrome MSS36
Advice about Serotonin syndrome (SS) summarising the causes, risk factors, diagnosis and management of serotonin syndrome.
Category: Medication Safety Series
Topic: Pharmacy
-
Medication Safety Series – Lithium for inpatients MSS2
Medication Safety information for staff about Lithium for inpatients.
Category: Medication Safety Series
Topic: Pharmacy
-
Pharmacological Management of Severe Agitation MSS21
Medication Safety Series document MSS21 Pharmacological Management of Severe Agitation supports the Trust's Rapid Tranquillisation Policy.
Category: Medication Safety Series
Topic: Pharmacy
-
-
-
Prescribing – record keeping and communication expectations MSS26
Document produced to highlight key record keeping and communication expectations when prescribing.
Category: Medication Safety Series
Topic: Pharmacy
-
Managing medicines safely in hot weather – MSS29
MSS29 - Managing medicines safely in hot weather gives guidance to patients, carers and staff to help stay safe and hydrated.
Category: Medication Safety Series
Topic: Pharmacy
-
MSS27 Clozapine-induced gastrointestinal hypomotility (CIGH)
This MSS guides staff to manage this risk associated with Clozapine which may impair motility of the entire gastrointestinal system.
Category: Medication Safety Series
Topic: Pharmacy
-
Lurasidone – PSS001
Prescribing Support Series document supporting safe prescribing of Lurasidone.
Category: Medication Safety Series
Topic: Pharmacy
